The role of NPY in metabolic homeostasis: implications for obesity therapy

Bibliography

• TATEMOTO K, CARLQUIST M, MUTT V: Neuropeptide Y —a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature (1982) 296:659–660.
   PubMed Web of Science ®Google Scholar
• ZUCKOWSKA-GROJEC Z, DAYAO E, KARWATOWSKA-PROKOPCZUK E, HAUSER G, DOODS H: Stress-induced mesenteric vasoconstriction is mediated by NPY Y1 receptors. Am.J. Pbysiol. (1996) 225:H700–H706.
   Google Scholar
• ZHANG Y, PROENCA R, MAFFEL M, BARONE M, LEOPOLD L, FRIEDMAN JM: Positional cloning of the mouse obese gene and its human homologue. Nature (1994) 372:425–432.
   PubMed Web of Science ®Google Scholar
• KENNEDY GC: The role of depot fat in the hypotha-lamic control of food intake in the rat. Proc. Roy. Soc. London Ser. B. (1953) 140:578–592.
   PubMed Web of Science ®Google Scholar
• INUI A: Feeding and body-weight regulation by hypothalamic neuropeptides — mediation of the actions of leptin. Trends Neurosci. (1999) 22:62–67.
   PubMed Web of Science ®Google Scholar
• LOFTUS TM: An adipocyte-central nervous system regulatory loop in the control of adipose homeostasis. Cell & Develop. Biol. (1999) 10:11–18.
   PubMed Web of Science ®Google Scholar
• KALRA SP, DUBE MG, PU S, XU B, HORVATH TL, KALRAPS: Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocr. Rev. (1999) 20(1):68–100.
   PubMed Web of Science ®Google Scholar
• SAHU A, KALRA SP: Neuropeptidergic regulation offeecling behavior by neuropeptide Y. Trends Endocrinol. Metab. (1993) 4:217–224.
   PubMed Web of Science ®Google Scholar
• ZARJEVSKI N, CUSIN I, VETTOR R et al.: Chronic intracerebroventricular neuropeptide-Y administra-tion to normal rats mimics hormonal and metabolic changes of obesity. Endocrinology(1993) 133:1753–1758.
   PubMed Web of Science ®Google Scholar
• •First conclusive demonstration that NPY has direct endocrine effects that contribute to NPY-induced obesity.
   Google Scholar
• SAHU A, KALRA PS, KALRA SP: Food deprivation and ingestion induce reciprocal changes in neuropeptide Y concentrations in the paraventricular nucleus. Peptides (1988) 9:83–86.
   PubMed Web of Science ®Google Scholar
• ERICKSON JC, CLEGG KE, PALMITER RD: Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature (1996) 381:415–421.
   PubMed Web of Science ®Google Scholar
• LARSEN PJ, TANG-CHRISTENSEN M, STIDSEN CE, MADSEN K, SMITH MS, CAMERON JL: Activation of central neuropeptide Y Y1 receptors potently stimulates food intake in male rhesus monkeys. J. Clin. Endocrinol. Metab. (1999) 84:3781–3791.
   PubMed Web of Science ®Google Scholar
• •The first paper showing the effects of NPY antagonists in primates.
   Google Scholar
• BRAMSHAD M, SONG CK, BARTNESS TJ: CNS origins of the sympathetic nervous system outflow to brown adipose tissue. Am. J. Physiol. (1999) 276:R1569–R1578.
   PubMed Web of Science ®Google Scholar
• BILLINGTON CJ, BRIGGS JE, HARKER S, GRACE M, LEVINE S: Neuropeptide Y in hypothalamic paraventricular nucleus: a center coordinating energy metabolism. Am. J. Physiol. Regulatory Integrative Comp. Physiol. (1994) 266:R1765–R1770.
   PubMedGoogle Scholar
• BING C, HOPKINS D, WANG Q, FRANKISH H, BUCKINGHAM R, WILLIAMS G: Direct stimulation of BAT thermogenesis does not affect hypothalamic neuropeptide Y. Peptides (1998) 19:167–170.
   PubMed Web of Science ®Google Scholar
• KALRA SP, DUBE MG, SAHU A, PHELPS CP, KALRA PS:Neuropeptide Y secretion increases in the paraven-tricular nucleus in association with increased appetite for food. Proc. Natl. Acad. Sci. USA(1991) 88:10931–10935.
   PubMed Web of Science ®Google Scholar
• MERCER JG, HOGGARD N, WILLIAMS LM et al.: Coexpres-sion of leptin receptor and preproneuropeptide Y mRNA in arcuate nucleus of mouse hypothalamus. J. Neuroendocrinol. (1996) 8:733–735.
   PubMed Web of Science ®Google Scholar
• BASKIN DG, BREININGER JF, SCHWARTZ MW: Leptin receptor mRNA identifies a subpopulation of neuropeptide Y neurons activated by fasting in rat hypothalamus. Diabetes (1999) 48:828–833.
   PubMed Web of Science ®Google Scholar
• OLLMANN MM, WILSON BD, YANG YK et al.: Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science (1997) 278:135–138.
   PubMed Web of Science ®Google Scholar
• HARROLD JA, WISSOWSON PS, WILLIAMS G: Altered energy balance causes selective changes in melanocortin-4 (MC4-R), but not melanocortin-3 (MC3-R), receptors in specific hypothalamic regions: further evidence that activation of MC4-R is a physio-logical inhibitor of feeding. Diabetes (1999) 48:267–271.
   PubMed Web of Science ®Google Scholar
• KASK A, RAGO L, KORROVITS P, WIKBERG JE, SCHIOTH HB: Evidence that orexigenic effects of Melanocortin 4 receptor antagonist HS014 are mediated by neuropep-tide Y. Biochem. Biophysical Res. Comm. (1998) 248:245–249.
   PubMed Web of Science ®Google Scholar
• EBIHARA K, OGAWA Y, KATSUURA G et al.: Involvementof agouti-related protein, an endogenous antagonist of hypothalamic melanocortin receptor, in leptin action. Diabetes (1999) 48:2028–2033.
   PubMed Web of Science ®Google Scholar
• KOTZ CM, BRIGGS JE, POMONIS JD, GRACE MK, LEVINEAS, BILLINGTON CJ: Neural site of leptin influence on neuropeptide Y signaling pathways altering feeding and uncoupling protein. Am. J. Physiol. (1998) 275:R478–R484.
   PubMed Web of Science ®Google Scholar
• KORNER J, CHUA JR SC, WILLIAMS JA, LEIBEL RL, WARDLAW SL: Regulation of hypothalamic proopio-melanocortin by leptin in lean and obese rats. Neuroendocrinology (1999) 70:377–383.
   PubMedGoogle Scholar
• HEINRICH SC, MENZAGHI F, PICH EM, HAUGER RL, KOOB GF: Corticotropin-releasing factor in the paraventricular nucleus modulates feeding induced by neuropeptide. Brain Res. (1993) 611:18–24.
   PubMed Web of Science ®Google Scholar
• GEHLERT DR, TINSLEY FC, ZIMMERMAN D et al.: Potentand selective nonpeptide Y1 receptor antagonists reduce food consumption and body weight in mice. 5th International NPY Meeting, Grand Cayman, Cayman Islands (1999) Abstract.
   Google Scholar
• EDWARDS CM, ABUSNANA S, SUNTER D, MURPHY KG,GHATEI MA, BLOOM SR: The effect of the orexins on food intake: comparison with neuropeptide Y, melanin-concentrating hormone and galanin. J. Endocrinol. (1999) 160:R7–R12.
   PubMed Web of Science ®Google Scholar
• YAMANAKA A, KUNII K, NAMBU T et al.: Orexin-inducedfood intake involves neuropeptide Y pathway. Brain Res. (2000) 859:404–409.
   PubMed Web of Science ®Google Scholar
• EVA C, KEINANEN K, MONYER H, SEEBURG P, SPRENGELR: Molecular cloning of a novel G protein coupled receptor that may belong to the neuropeptide family. FESS Lett. (1990) 271:81–84.
   PubMed Web of Science ®Google Scholar
• KRAUSE J, EVA C, SEEBURG P, SPRENGEL R: Neuropep-tide Y1 subtype pharmacology of recombinantly expressed neuropeptide receptor. Mol. Pharmacol. (1992) 41:817–821.
   PubMed Web of Science ®Google Scholar
• FUXE K, TINNER B, CABERLOTTO L, BUNNEMANN B, AGNATI LF: NPY Y1 receptor like irnmunoreactivity exists in a subpopulation of beta-endorphin irnmuno-reactive nerve cells in the arcuate nucleus: a double irnmunolabelling analysis in the rat. Neurosci. Lett. (1997) 225:49–52.
   PubMed Web of Science ®Google Scholar
• ROCHE C, BOUTIN P, DINA C et al.: Genetic studies ofneuropeptide Y and neuropeptide Y receptors Y1 and Y5 regions in morbid obesity. Diabetologia (1997) 40:671–675.
   PubMed Web of Science ®Google Scholar
• GRUNDEMAR L, HAKANSON R: Neuropeptide Y effectorsystems: perspectives for drug development. Trends Biochem. Sci. (1994) 15:153–158.
   Web of Science ®Google Scholar
• BECK-SICKINGER AG, WIELAND HA, WITTNEBEN H; WILIM KD, RUDOLF K, JUNG G: Complete L-alanine scan of neuropeptide Y reveals ligand binding to Y1 and Y2 receptors with distinguished conformations. Eur. J. Biochem. (1994) 225:947–958.
   PubMedGoogle Scholar
• WIELAND HA, WILLIM K, DOODS HN: Receptor binding profiles of NPY analogues and fragments in different tissues and cell lines. Peptides (1995) 16:1389–1394.
   PubMed Web of Science ®Google Scholar
• ROSE PM, FERNANDES P, LYNCH JS et al.: Cloning and functional expression of a cDNA encoding a human type 2 neuropeptide Y receptor. J. Biol. Chem. (1995) 270:22661–22664.
   PubMed Web of Science ®Google Scholar
• INGENHOVE N, ECKARD CP, GEHLERT DR, BECK-SICKINGER AG: Molecular characterization of the human neuropeptide Y Y2 receptor. Biochem. (1999) 38:6897–6902.
   PubMed Web of Science ®Google Scholar
• CABERLOTTO L. FUXE K, RIMLAND JM et al.: Regionaldistribution of neuropeptide Y Y2 receptor messenger RNA in the human post mortem brain. Neuroscience (1998) 86:167–178.
   Google Scholar
• GUSTAFSON EL, SMITH KE, DURKIN MM et al.: Distribu-tion of the neuropeptide Y Y2 receptor mRNA in rat central nervous system. Mol. Brain Res. (1997) 46:223–235.
   PubMedGoogle Scholar
• BROBERGER CH, LANDRY M, WONG H et al.: Subtypes Y1 and Y2 of the neuropeptide Y receptor are respectively expressed in proopiomelanocortin- and neuropeptide Y containing neurons of the rat hypothalamic arcuate nucleus. Neuroendocrinology (1997) 66:393–408.
   PubMed Web of Science ®Google Scholar
• SCHWARTZ TW, FUHLENDORFF J, KJEMS LL et al.: Signal epitopes in the three-dimensional structure of neuropeptide Y: interaction with Yl, Y2 and pancre-atic polypeptide receptors. Ann. NY Acad. Sci. (1990) 611:35–47.
   PubMed Web of Science ®Google Scholar
• MICHEL MC, BECK-SICKINGER AG, COX H, DOODS HN: XVI. International Union of Pharmacology Recommendations for the nomenclature of neuropep-tide Y, Peptide YY and pancratic polypeptide receptors. Pharmacol. Rev. (1998) 50:143–150.
   PubMed Web of Science ®Google Scholar
• GLAUM SR, MILLER RJ, RHIM H et al.: Characterization of Y3 receptor mediated synaptic inhibition by chimeric neuropeptide Y-peptide YY peptides in the rat brainstem. Br. J. Pharmacol. (1997) 120:481–487.
   PubMed Web of Science ®Google Scholar
• DUMONT Y, CADIEUC A, PHENG LH et al.: Peptide YY derivatives as selective neuropeptide Y/peptideYY Y1 and Y2 agonists devoid of activity for the Y3 receptor subtype. Mol. Brain Res. (1994) 26:320–324.
   PubMedGoogle Scholar
• LUNDELL I, BLOMQVIST AG, BERGLUND MM et al.: Cloning of a human receptor of the NPY receptor family with high affinity for pancreatic polypeptide and peptide YY. J. Biol. Chem. (1995) 270:29123–29128.
   PubMed Web of Science ®Google Scholar
• SCHWARTZ TW: Pancreatic polypeptide: a hormone under vagal control. Gastroenterology (1983) 85:1411–1425.
   PubMed Web of Science ®Google Scholar
• TRINH T, VAN DUMONT Y, QUIRION R: High levels of specific neuropeptide Y/pancreatic polypeptide receptors in the rat hypothalamus and brainstem. Eur. J. Pharmacol. (1996) 318:R1–R3.
   PubMed Web of Science ®Google Scholar
• GERALD C, WALKER MW, CRISCIONE L et al.: A receptor subtype involved in neuropeptide-Y-induced food intake. Nature (1996) 382:168–171.
   PubMed Web of Science ®Google Scholar
• HU Y, BLOOMQUIST TB, CORNFILED LJ et al.: Identifica-tion of a novel hypothalamic neuropeptide Y receptor associated with feeding behavior. J. Biol. Chem. (1996) 271:26315–26319.
   PubMed Web of Science ®Google Scholar
• DUMONT Y, FOURNIER A, QUIRION R: Expression and characterization of the neuropeptide Y Y5 receptor subtype in the rat brain./ Neurosci. (1998) 18:5565–5574.
   PubMed Web of Science ®Google Scholar
• STATNICK MA, SCHOBER DA, GACKENHEIMER S et al: Characterizaion of the neuropeptide Y5 receptor in the human hypothalamus: a lack of correlation between Y5 mRNA levels and binding sites. Brain Res. (1998) 810:16–26.
   PubMed Web of Science ®Google Scholar
• ROSENKRANZ K, HINNEY A, ZIEGLER A et al.: Screeningfor mutations in the neuropeptide Y Y5 receptor gene in cohorts belonging to different weight extremes. Int. J. Obes. Relat. Metab. Disorder (1998) 22:157–163.
   PubMed Web of Science ®Google Scholar
• MATSUMOTO M, NOMURA T, MOMOSE K et al.: Inactiva-tion of a novel Neuropeptide Y/Peptide YY receptor gene in primate species./ Biol. Chem. (1996) 271:27217–27220.
   PubMed Web of Science ®Google Scholar
• GREGOR P, FENG Y, DECARR LB, CORNFIELD J, MCCALEBML: Molecular characterization of a second mouse pancreatic polypeptide receptor and its inactivated human homologue. J. Biol. Chem. (1996) 271:27776–27781.
   PubMed Web of Science ®Google Scholar
• WEINBERG DH, SIRINATHSINGHJI DJS, TAN CP, et al.:Cloning and expression of a novel neuropeptide Y receptor. J. Biol. Chem. (1996) 271:16435–16438.
   Google Scholar
• LING A, ANTHONY L: Neuropeptide Y receptor antago-nists. Exp. Opin. Ther. Patents (1999) 9:375–384.
   Web of Science ®Google Scholar
• WIELAND HA, ENGEL W, EBERLEIN W, RUDOLF K, DOODS HN: Subtpye selectivity of the novel nonpep-tide neuropeptide Y Y1 receptor antagonist BIB03304 and its effect on feeding in rodents. Br. J. Pharmacol. (1998) 125:549–555.
   PubMed Web of Science ®Google Scholar
• MURAKAMIY, HARA H, OKADA T et al.: 1,3-Disubstitutedbenzazepines as novel, potent, selective neuropeptideY Y1 receptor antagonists. J. Med. Chem. (1999) 42:2621–2632.
   PubMed Web of Science ®Google Scholar
• HIPSKIND PA, LOBB KI, NIXON JA et al.: Potent andselective 1,2,3-trisubstituted indole NPY Y-1 antago-nists. J. Med. Chem. (1997) 40:3712–3714.
   PubMed Web of Science ®Google Scholar
• ZARRINMAYEH H, NUNES AM, ORNSTEIN PL et al.: Synthesis and evaluation of a series of novel 2[(4-Chlorophenoxy)methyl]benzimidazoles as selective neuropeptide Y Y1 receptor antagonists. J. Med. Chem. (1998) 41:2709–2719.
   PubMed Web of Science ®Google Scholar
• ZARRINMAYEH H, ZIMMERMAN DM, CANTRELL BE et al.:Structure-activity relationship of a series of diarninoalkyl substituted benzirnidazole as neuropep-tide Y Y1 receptor antagonists. Bioorg. Med. Chem. Lett. (1999) 9:647–652.
   PubMed Web of Science ®Google Scholar
• BRITTON TC, SPINAZZE PG, HIPSKIND PA et al.:Structure-activity relationships of a series of benzothiophene-derived NPY Y1 antagonists: optimi-zation of the C-2 side chain. Bioorg. Med. Chem. Lea. (1999) 9:475–480.
   PubMed Web of Science ®Google Scholar
• KANATANI A, KANNO T, ISHIHARA A et al.: The novel neuropeptide Y Y1 receptor antagonist J-104870: a potent feeding suppressant with oral bioavailability. Biochem. Biophys. Res. Commun. (1999) 266:88–91.
   PubMed Web of Science ®Google Scholar
• DOODS H, GAIDA W, WIELAND HA et al.: B11E0246: A selective and high affinity neuropeptide Y Y2 receptor antagonist. Eur. J. Pharmacol. (1999) 384(2/3):R3–R5.
   Google Scholar
• CRISCIONE L, RIGOLLIER P, BATZL-HARTMANN C et al.: Food intake in free-feeding and energy-deprived lean rats is mediated by the neuropeptide Y5 receptor. J. Clin. Invest. (1998) 102:2136–2145.
   PubMed Web of Science ®Google Scholar
• YOUNGMAN MA, MCNALLY JJ, LOVENBERG TW et al.: a-Substituted N-(Sulfonarnido)alkyl-p-aminotetralins: potent and selective Neuropeptide Y Y5 receptor antagonists. J. Med. Chem. (2000) 43:346–350.
   PubMed Web of Science ®Google Scholar
• STANLEY BG, MAGDALIN W, SEIRAFI A, NGUYEN MM, LEIBOWITZ SF: Evidence for neuropeptide Y mediation of eating produced by food deprivation and for a variant of the Y1 receptor mediating this peptide's effect. Peptides (1992) 13:581–587.
   PubMed Web of Science ®Google Scholar
• KALRA SP, DUBE MG, FOURNIER A, KALRA PS. Structure-function analysis of stimulation of food intake by neuropeptide Y: effects of receptor agonists. Physiol. Behav. (1991) 50:5–9.
   PubMed Web of Science ®Google Scholar
• HWA JJ, WITTEN MB, WILLIAMS P et al.: Activation of theNPY Y5 receptor regulates both feeding and energy expenditure. Am. J. Physiol. (1999) 277:R1428–R1434.
   PubMed Web of Science ®Google Scholar
• WYSS P, LEVENS N, STRICKER-KRONGRAD A: Stimula-tion of feeding in lean but not in obese Zucker rats by a selective neuropeptide Y Y5 receptor agonist. Neurore-port (1998) 9:2675–2677.
   PubMed Web of Science ®Google Scholar
• MCCREA K, WISIALOWSKI T, CABRELE C et al.: 2-36K4,RYYSA19-23WP a novel Y5-receptor prefer-ring ligand with strong stimulatory effect on food intake. Regul. Pept. (2000) 87:47–58.
   PubMed Web of Science ®Google Scholar
• HAYNES AC, ARCH JRS, WILSON S, MCCLUE S, BUCKINGHAM RE: Characterisation of the neuropep-tide Y receptor that mediates feeding in the rat: a role for the Y5 receptor? Regul. Pept. (1998) 75–76:355–361.
   Google Scholar
• PALMITER RD, ERICKSON JC, HOLLOPETER G, BARABAN SC, SCHWARTZ MW: Life without neuropeptide Y. Recent Prog. Hormone Res. (1998) 53:163–199.
   PubMedGoogle Scholar
• •Overview of lack of NPY in genetic models of obesity as well as in chemically-induced models of obesity.
   Google Scholar
• ERICKSON JC, HOLLOPETER G, PALMITER RD: Attenua-tion of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y. Science (1996) 274:1704–1708.
   PubMed Web of Science ®Google Scholar
• HOLLOPETER G, ERICKSON JC, SEELEY RJ, MARSH DJ, PALMITER RD: Response of neuropeptide Y-deficient mice to feeding effectors. Regul. Pep. (1998) 75–76:383–389.
   Google Scholar
• SCHWARTZ M, ERICKSON J, BASKIN D, PALMITER R: Effect of fasting and leptin deficiency on hypotha-lamic neuropeptide Y gene transcription in vivo revealed by expression of a lacZ reporter gene. Endocrinology (1998) 139:2629–2635.
   PubMed Web of Science ®Google Scholar
• PEDRAZZINI T, SEYDOUX J, KONSTNER P et al.: Cardio-vascular response, feeding behavior and locomotor activity in mice lacking the NPY Y1 receptor. Nature Med. (1998) 4:722–726.
   PubMed Web of Science ®Google Scholar
• KUSHI A, SASAI H, KOIZUMI H, TAKEDA N, YOKOYAMA M, NAKAMURA M: Obesity and mild hyperinsulinemia found in neuropeptide Y-Y1 receptor-deficient mice. Proc. Natl. Acad. Sci. USA (1998) 95:15659–15664.
   PubMed Web of Science ®Google Scholar
• NAVEILHAN P, HASSANI H, CANALS JM et al.: Normalfeeding behavior, body weight and leptin response require the neuropeptide Y Y2 receptor. Nature Med. (1999) 5:1188–1193.
   PubMed Web of Science ®Google Scholar
• MARSH DJ, HOLLOPETER G, KAFER KE, PALMITER RD: Role of the Y5 neuropeptide Y receptor in feeding and obesity. Nature Med. (1998) 4:718–721.
   PubMed Web of Science ®Google Scholar
• AKABAYASHI A, WAHLESTED C, ALEXANDER JT et al.: Specific inhibition of endogenous neuropeptide Y synthesis in arcuate nucleus by antisense oligonucleo-tides suppresses feeding behavior and insulin secretion. Mol. Brain Res. (1994) 21:55–61.
   PubMedGoogle Scholar
• SCHAFFHAUSER AO, STRICKER-KRONGRAD L, BRUNNER I et al.: Inhibition of food intake by neuropeptide Y Y5 receptor antisense oligodeoxynucleotides. Diabetes (1997) 46: 1792-1798.
   Google Scholar
• DRYDEN S, PICKAVANCE L, TIDD D, WILLIAMS G: Thelack of specificity of neuropeptide Y (NPY) antisense oligodeoxynucleotides administered intracerebrov-entricularly in inhibiting food intake and NPY gene expression in the rat hypothalamus. J. Endocrinol. (1998) 157:169–175.
   PubMed Web of Science ®Google Scholar
• LOPEZ-VALPUESTA FJ, NYCE JW, MYERS RD: NPY-Y1receptor antisense injected centrally in rats causes hyperthermia and feeding. Neuroreport (1996) 7:2781–2784.
   PubMed Web of Science ®Google Scholar
• HULSEY MG, PLESS CM, WHITE BD, MARTIN RJ: ICV administration of anti-NPY antisense oligonucleotide: effects on feeding behavior, body weight, peptide content and peptide release. Regul. Pept. (1995) 59:207–214.
   PubMed Web of Science ®Google Scholar
• HEILIG M: Antisense inhibition of neuropeptide Y (NPY)-Y1 receptor expression blocks the anxiolytic-like action of NPY in amygdala and paradoxically increases feeding. Regul. Pept. (1995) 59:201–205.
   PubMed Web of Science ®Google Scholar
• LOPEZ-VALPUESTA FJ, NYCE JW, GRIFFIN-BIGGS TA, ICE JC, MYERS RD: Antisense to NPY-Y1 demonstrates that Y1 receptors in the hypothalamus underlie NPY hypothermia and feeding in rats. Proc. R. Soc. Lond. (Biol) (1996) 263:881–886.
   PubMed Web of Science ®Google Scholar
• WIELAND HA, HAMILTON BS, KRIST B: Hammerhead ribozymes that selectively cleave the NPY Yl, Y4, and Y5 receptor full-length RNA. Antisense Nucleic Acid Drug Dev. (1998) 8:435–440.
   PubMedGoogle Scholar
• TANG-CHRISTENSEN M, KRISTENSEN P, STIDSEN CE, BRAND CL, LARSEN PJ: Central administration of Y5 receptor antisense decreases spontaneous food intake and attenuates feeding in response to exogenous neuropeptide Y. J. Endocrinol. (1998) 159:307–312.
   PubMed Web of Science ®Google Scholar
• FLYNN MC, TURRIN NP, PLATA-SALAMAN CR, FRENCH-MULLEN JM: Feeding response to neuropeptide Y-related compounds in rats treated with Y5 receptor antisense or sense phosphothiooligodeoxynucleo-tide. Physiol. Behav. (1999) 66:881–884.
   PubMed Web of Science ®Google Scholar
• DANIELS AJ, MATHEWS JE, SLEPETIS RJ et al.: High-affinity neuropeptide Y receptor antagonists. Proc. Natl. Acad. Sci. USA (1995) 92:9067–9071.
   PubMed Web of Science ®Google Scholar
• KANATANI A, ISHIHARA A, ASAHI 5, TANAKA T, OZAKI S,IHARA M: Potent neuropeptide Y Y1 receptor antago-nist 1229E91: blockade of neuropeptide Y-induced and physiological food intake. Endocrinology (1996) 137:3177–3182.
   PubMed Web of Science ®Google Scholar
• IYENGAR 5, LI DL, SIMMONS RMA: Characterization ofNeuropeptide Y-induced feeding in mice: Do yl-Y6 receptor subtypes mediate feeding? J. Pharmacol. Exp. Ther. (1999) 289:1031–1040.
   PubMed Web of Science ®Google Scholar
• KANATANI A, FUKAMI T, FUKURODA T et al.: Y5 receptors are not involved in physiologically relevant feeding in rodents. Regul. Pept. (1997) 71:212.
   Google Scholar
• KANATANI A, MASHIKO S, MURAI N eta/.: Key role of the Y1 receptor in NPY mediated feeding regulation: comparative studies of Y1 and Y5 receptor deficient mice. 5th Intern. NPY Meeting (1999), Grand Cayman, Cayman Islands (Abstract).
   Google Scholar
• KALRA SP, DUBE MG, XU B, FARMERIE WG, KALRA SP: Neuropeptide Y (NPY) Y1 receptor mRNA is upregu-lated in association with transient hyperphagia and body weight gain: Evidence for a hypothalamic site for concurrent development of leptin resistance. J. Neuroendocrinol. (1998) 10:43–49.
   PubMed Web of Science ®Google Scholar
• KANATANI A, ITO J, ISHIHARA A et al.: NPY-induced feeding involves the action of Yl-like receptor in rodents. Regul. Pept. (1998) 75–76:409–415.
   Google Scholar
• CASSELLA JV: The preclinical profile of NGD 95–1: A selective, orally-active NPY1 antagonist. Abstract at the Summer Neuropeptide Conference Key West, Florida, USA (1999).
   Google Scholar
• HEGDE SS, BONHAUS DW, STANLEY W et al.: Pharma-cological evaluation of 1229E91, a novel high-affinity and selective neuropeptide Y-Y1 receptor antagonist. J. Pharmacol. Exp. Ther. (1995) 275:1261–1266.
   PubMed Web of Science ®Google Scholar
• WRIGHT J, BOLTON G, CRESWELL M et al.: 8-Amino-6-(arylsulfony1)-5-nitroquinolines: novel nonpeptide neuropeptide Y1 receptor antagonists. Bioorg. Med. Chem. Lea. (1996) 6:1809–1814.
   Web of Science ®Google Scholar
• LING AL, MAZUROV A, KROKHINA G et al.: Chemistry of bis-dihydrotriazines: Rearrangement leading to the identification of neuropeptide Y receptor antagonists. 216th ACS National Meeting, Boston, USA, August (1998).
   Google Scholar
• MCNALLY JJ, YOUNGMAN MA, LOVENBERG TW, NEPOMUCENO DH, WILSON SJ, DAX SL: N-(sulfona-mido)alky[tetrahydro-1H-benzo[e]indo1-2-yl]amines: potent antagonists of human neuropeptide Y Y5 receptor. Bioorg. Med. Chem. Lett. (2000) 10:213–216.
   PubMed Web of Science ®Google Scholar
• KORDIK CP, REITZ AB: Pharmacological treatment of obesity: therapeutic strategies. J. Med. Chem. (1999) 42:181–201.
   PubMed Web of Science ®Google Scholar